Stay updated on Pembrolizumab & ATRA combo in Adv. Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & ATRA combo in Adv. Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab & ATRA combo in Adv. Melanoma Clinical Trial page
- Check5 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check12 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check19 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an opportunity for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check26 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check48 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check62 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed information about a Phase I/Ib clinical trial for advanced melanoma treatments and the addition of new identifiers and collaborators. The revision number has also been updated.SummaryDifference37%
Stay in the know with updates to Pembrolizumab & ATRA combo in Adv. Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & ATRA combo in Adv. Melanoma Clinical Trial page.